Trial Profile
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2011
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Gram-negative infections; Nosocomial pneumonia
- Focus Pharmacodynamics; Pharmacokinetics
- 14 Nov 2011 New trial record